Mural Oncology plc (NASDAQ: MURA)
$3.3400
-0.0300 ( -0.89% ) 28.1K
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
Market Data
Open
$3.3400
Previous close
$3.3700
Volume
28.1K
Market cap
$57.32M
Day range
$3.3100 - $3.3700
52 week range
$2.8800 - $6.2499
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4/a | Other | 1 | Apr 11, 2024 |
8-k | 8K-related | 14 | Mar 26, 2024 |
10-k | Annual reports | 98 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
8-k | 8K-related | 40 | Jan 08, 2024 |
4 | Insider transactions | 1 | Dec 18, 2023 |
4 | Insider transactions | 1 | Dec 18, 2023 |
4 | Insider transactions | 1 | Dec 18, 2023 |
4 | Insider transactions | 1 | Dec 18, 2023 |